Talphera Inc (TLPH)

$1.05 +0.02 (1.94%)
Market Cap 48.01M
Revenue (ttm) 0.00
Net Income (ttm) -13.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 78,832
Avg Vol 407,198
Day's Range N/A - N/A
Shares Out 46.61M
Stochastic %K 19%
Beta 0.30
Analysts Strong Sell
Price Target $3.25

Company Profile

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 650 216 3500
Address:
1850 Gateway Drive, Suite 175, San Mateo, United States
Brunoez
Brunoez Jan. 14 at 4:15 PM
$TLPH For better or for worse, it appears that the share price of TLPH is tied to that of CRMD. Let's hope CRMD rebounds soon.
1 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Jan. 13 at 7:53 PM
$TLPH
0 · Reply
golfguy42360
golfguy42360 Jan. 13 at 6:30 PM
$CRMD Maybe we can drop so low $TLPH can buy us.
1 · Reply
Miketj
Miketj Jan. 13 at 4:22 PM
$TLPH waiting for my .98 and .99s to fill😎
0 · Reply
nazzangr
nazzangr Jan. 13 at 3:40 PM
$TLPH i think i brought this up when crmd first announced their interest in tlph. They recently aquired melinda? Forgot the name of the company so I knew they would be tight but Joe definitely knows that as well. The thing is that once tlph gets this approved whether crmd acquires tlph or not, both sides will benefit.
1 · Reply
Brunoez
Brunoez Jan. 13 at 3:36 PM
$TLPH So far, I've been operating with a belief that CRMD's strong interest in TLPH would be a positive moving forward. Given the history of stock manipulation of CRMD, however, now I'm having second thoughts. Joe may be looking for a cheap buy.
0 · Reply
S2730
S2730 Jan. 13 at 3:29 PM
$TLPH $CRMD At least I’m not the only one that sucks at investing. Joe’s investment is starting to whither away too.
2 · Reply
nazzangr
nazzangr Jan. 13 at 2:55 PM
$TLPH will continue to sink til some news..generally bio only goes up with good news :(
0 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Jan. 13 at 12:33 PM
$TLPH
0 · Reply
Aawilliam2003
Aawilliam2003 Jan. 13 at 2:12 AM
$TLPH can anyone explain how CRMD can acquire TLPH? They only have $150M in cash and using stock to buy is out the window with the stock in the tank. Seems like deal is off
3 · Reply
Latest News on TLPH
Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:11 PM EST - 2 months ago

Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 12, 2025, 4:05 PM EST - 2 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

CRMD

Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

Nov 5, 2025, 4:05 PM EST - 2 months ago

Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

Talphera Announces the Appointment of Joe Todisco to Board of Directors

Oct 21, 2025, 8:30 AM EDT - 3 months ago

Talphera Announces the Appointment of Joe Todisco to Board of Directors

CorMedix Announces Strategic Minority Investment in Talphera

Sep 8, 2025, 8:30 AM EDT - 4 months ago

CorMedix Announces Strategic Minority Investment in Talphera

CRMD

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

Sep 8, 2025, 8:30 AM EDT - 4 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

CRMD

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Aug 25, 2025, 8:30 AM EDT - 5 months ago

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:10 PM EDT - 5 months ago

Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 14, 2025, 4:05 PM EDT - 5 months ago

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

Aug 7, 2025, 4:35 PM EDT - 5 months ago

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript

May 14, 2025, 9:01 PM EDT - 8 months ago

Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

May 14, 2025, 4:05 PM EDT - 8 months ago

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

May 7, 2025, 4:05 PM EDT - 8 months ago

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 6:33 PM EDT - 10 months ago

Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 31, 2025, 4:05 PM EDT - 10 months ago

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Mar 31, 2025, 8:30 AM EDT - 10 months ago

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Mar 26, 2025, 4:38 PM EDT - 10 months ago

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Jan 14, 2025, 8:30 AM EST - 1 year ago

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:43 PM EST - 1 year ago

Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024, 4:05 PM EST - 1 year ago

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 4:54 PM EDT - 1 year ago

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 4:15 PM EDT - 1 year ago

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Aug 19, 2024, 8:30 AM EDT - 1 year ago

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 6:39 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

Aug 5, 2024, 4:05 PM EDT - 1 year ago

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 20, 2024, 5:25 PM EDT - 1 year ago

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Talphera to Participate at A.G.P. Virtual Healthcare Conference

May 16, 2024, 5:45 PM EDT - 1 year ago

Talphera to Participate at A.G.P. Virtual Healthcare Conference

Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript

May 14, 2024, 6:21 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 14, 2024, 4:05 PM EDT - 1 year ago

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

May 2, 2024, 4:15 PM EDT - 1 year ago

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 9:48 PM EST - 2 years ago

Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

Mar 6, 2024, 4:05 PM EST - 2 years ago

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

Mar 1, 2024, 7:30 AM EST - 2 years ago

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

Feb 26, 2024, 4:15 PM EST - 2 years ago

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

Jan 18, 2024, 8:30 AM EST - 2 years ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

Brunoez
Brunoez Jan. 14 at 4:15 PM
$TLPH For better or for worse, it appears that the share price of TLPH is tied to that of CRMD. Let's hope CRMD rebounds soon.
1 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Jan. 13 at 7:53 PM
$TLPH
0 · Reply
golfguy42360
golfguy42360 Jan. 13 at 6:30 PM
$CRMD Maybe we can drop so low $TLPH can buy us.
1 · Reply
Miketj
Miketj Jan. 13 at 4:22 PM
$TLPH waiting for my .98 and .99s to fill😎
0 · Reply
nazzangr
nazzangr Jan. 13 at 3:40 PM
$TLPH i think i brought this up when crmd first announced their interest in tlph. They recently aquired melinda? Forgot the name of the company so I knew they would be tight but Joe definitely knows that as well. The thing is that once tlph gets this approved whether crmd acquires tlph or not, both sides will benefit.
1 · Reply
Brunoez
Brunoez Jan. 13 at 3:36 PM
$TLPH So far, I've been operating with a belief that CRMD's strong interest in TLPH would be a positive moving forward. Given the history of stock manipulation of CRMD, however, now I'm having second thoughts. Joe may be looking for a cheap buy.
0 · Reply
S2730
S2730 Jan. 13 at 3:29 PM
$TLPH $CRMD At least I’m not the only one that sucks at investing. Joe’s investment is starting to whither away too.
2 · Reply
nazzangr
nazzangr Jan. 13 at 2:55 PM
$TLPH will continue to sink til some news..generally bio only goes up with good news :(
0 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Jan. 13 at 12:33 PM
$TLPH
0 · Reply
Aawilliam2003
Aawilliam2003 Jan. 13 at 2:12 AM
$TLPH can anyone explain how CRMD can acquire TLPH? They only have $150M in cash and using stock to buy is out the window with the stock in the tank. Seems like deal is off
3 · Reply
Miketj
Miketj Jan. 12 at 11:15 PM
$TLPH previous post was my explanation as why I thought back in mid December this would get to .97 😎✌️
0 · Reply
Miketj
Miketj Jan. 12 at 11:11 PM
$TLPH GLA😎
0 · Reply
Noname2022
Noname2022 Jan. 12 at 4:57 PM
$CRMD $AKBA $TLPH CRMD strategic investment in TLPH = Q4 Vafseo sales (~$5M)
0 · Reply
BigTpain
BigTpain Jan. 12 at 3:48 PM
$TLPH
0 · Reply
Brunoez
Brunoez Jan. 12 at 3:04 PM
$TLPH Any guesses on the share price when good news is announced on enrollment?? I"m hoping for $1.50.
0 · Reply
WARRENBUFFETSIGNAL
WARRENBUFFETSIGNAL Jan. 12 at 3:02 PM
$TLPH
0 · Reply
Miketj
Miketj Jan. 12 at 2:39 PM
$TLPH I guess all I takes is being cute adding more under 1😎
1 · Reply
Miketj
Miketj Jan. 12 at 2:38 PM
$TLPH nice
0 · Reply
Miketj
Miketj Jan. 12 at 2:35 PM
$TLPH added thank you😎
0 · Reply
Crandaddy01
Crandaddy01 Jan. 12 at 2:26 PM
$TLPH
0 · Reply
Brunoez
Brunoez Jan. 12 at 1:53 PM
$TLPH I put a bid in for 10K shares @ $1.05 on Friday and only filled 100 shares. I'll actually be very happy if it never fills.
1 · Reply
_nic
_nic Jan. 12 at 9:21 AM
$TLPH pm +10% cnbc shows Zero
0 · Reply